AWA
WST icon

Aaron Wealth Advisors’s West Pharmaceutical WST Stock Holding History

Aaron Wealth Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$581K Buy
+1,617
New +$494K 0.03% 382
2025
Q4 		– Sell
-1,049
Closed -$275K – 719
2025
Q3 		$275K Buy
+1,049
New +$255K 0.02% 544
2022
Q2 		– Sell
-159
Closed -$65.3K – 852
2022
Q1 		$65.3K Buy
+159
New +$62.2K 0.02% 368

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Aaron Wealth Advisors's WST Position: Q2 2026 in Review

Aaron Wealth Advisors opened a new position in West Pharmaceutical (WST) in Q2 2026: 1,617 shares worth $581K. The stake represents 0.03% of the portfolio and ranks #382 among its holdings. This is a return to the name: Aaron Wealth Advisors previously reported a position in WST as recently as Q3 2025.

Aaron Wealth Advisors first reported a position in WST in Q1 2022 and has held it in 3 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Aaron Wealth Advisors held 1,617 shares of West Pharmaceutical worth $581K as of Q2 2026.
  • West Pharmaceutical was a new Aaron Wealth Advisors position in Q2 2026.
  • West Pharmaceutical made up 0.03% of Aaron Wealth Advisors's portfolio in Q2 2026, its #382 holding.
  • Aaron Wealth Advisors first reported a position in West Pharmaceutical in Q1 2022 and has held it in 3 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Aaron Wealth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.